Epcoritamab plus R-DHAX/C achieved 79% ORR and 69% CR, with median 1.4 months to response and early activity evident by the first week-6 assessment. Over half of patients reached ASCT after ...
Interesting Engineering on MSN
Bell’s new 517 mph-speeding aircraft for DARPA’s SPRINT program passes design review
In military aviation, the runway has always been a tether. It provides the distance ...
Engineers know that energy modeling is a moving target. Trying to both design sustainable buildings and meet more-stringent government and client-imposed clean energy and carbon reduction goals has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results